Fatal infections in older patients with inflammatory bowel disease on anti-tumor necrosis factor therapy
Way-Seah Lee, Najib Azmi, Ruey-Terng Ng, Sik-Yong Ong, Sasheela Sri La Ponnampalavanar, Sanjiv Mahadeva, Ida Hilmi
Intest Res. 2017;15(4):524-528.   Published online 2017 Oct 23     DOI: https://doi.org/10.5217/ir.2017.15.4.524
Citations to this article as recorded by Crossref logo
Systemic lupus erythematosus complicated by Crohn’s disease with rectovaginal fistula
Heng Yeh, Ren-Chin Wu, Wen-Sy Tsai, Chia-Jung Kuo, Ming-Yao Su, Cheng-Tang Chiu, Puo-Hsien Le
BMC Gastroenterology.2021;[Epub]     CrossRef
Systematic review with meta-analysis: biologics and risk of infection or cancer in elderly patients with inflammatory bowel disease
Daniele Piovani, Silvio Danese, Laurent Peyrin-Biroulet, Georgios K. Nikolopoulos, Stefanos Bonovas
Alimentary Pharmacology & Therapeutics.2020; 51(9): 820.     CrossRef
Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis
Nienke Z. Borren, Ashwin N. Ananthakrishnan
Clinical Gastroenterology and Hepatology.2019; 17(9): 1736.     CrossRef
Improving Quality in the Care of Patients with Inflammatory Bowel Diseases
Matthew D Egberg, Ajay S Gulati, Ziad F Gellad, Gil Y Melmed, Michael D Kappelman
Inflammatory Bowel Diseases.2018; 24(8): 1660.     CrossRef